{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-084266","form_type":"8-K","ticker":"NAMS","cik":"0001936258","company_name":"NewAmsterdam Pharma Co N.V.","filed_at":"2026-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.820856+00:00","generated_at":"2026-05-15T22:49:16.967226+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"NewAmsterdam Pharma files updated corporate presentation, no specific details disclosed","bullets":["Company posted an updated investor presentation on its website on March 2, 2026.","Presentation furnished as Exhibit 99.1 to this Form 8-K but not reproduced in available text.","No financial or operational updates explicitly provided in the filing text.","Content of the presentation is unknown; cannot extract specific numbers or events.","Confidence low due to lack of exhibit content and absence of material disclosures."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-084266","json":"https://secwatch.observer/filing/0001193125-26-084266.json","markdown":"https://secwatch.observer/filing/0001193125-26-084266.md","text":"https://secwatch.observer/filing/0001193125-26-084266.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526084266/0001193125-26-084266-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526084266/nams-20260302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:49:16.967226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}